Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIT | P10721 | 2/20 | 0.54 |
| ▸ | AKT2 | P31751 | 9/20 | 0.53 |
| ▸ | JAK3 | P52333 | 7/20 | 0.44 |
| ▸ | JAK2 | O60674 | 6/20 | 0.44 |
| ▸ | JAK1 | P23458 | 6/20 | 0.44 |
| ▸ | AKT1 | P31749 | 6/20 | 0.43 |
| ▸ | TYK2 | P29597 | 2/20 | 0.42 |
| ▸ | ROCK2 | O75116 | 5/20 | 0.41 |
| ▸ | AKT3 | Q9Y243 | 5/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.41 |
| ▸ | TTBK1 | Q5TCY1 | 1/20 | 0.41 |
| ▸ | TTBK2 | Q6IQ55 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL324213 | 0.89 | JAK3 (0.55) | AKT2JAK3JAK2JAK1AKT1 | |
| SCHEMBL323926 | 0.89 | AKT1 (0.55) | KITAKT2JAK3JAK2JAK1 | |
| SCHEMBL323781 | 0.88 | JAK3 (0.53) | AKT2JAK3JAK2JAK1AKT1 | |
| SCHEMBL322722 | 0.87 | AKT1 (0.54) | KITAKT2AKT1ROCK2AKT3 | |
| SCHEMBL325110 | 0.86 | AKT1 (0.53) | AKT2JAK3JAK2JAK1AKT1 | |
| SCHEMBL323241 | 0.86 | JAK3 (0.46) | KITAKT2JAK3JAK2JAK1 | |
| SCHEMBL324613 | 0.86 | JAK3 (0.53) | AKT2JAK3JAK2JAK1AKT1 | |
| SCHEMBL324666 | 0.86 | JAK3 (0.52) | KITAKT2JAK3JAK2JAK1 | |
| SCHEMBL323886 | 0.85 | AKT2 (0.51) | AKT2JAK3JAK2JAK1AKT1 | |
| SCHEMBL324306 | 0.84 | KIT (0.52) | KITAKT2JAK3JAK2JAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2590981-A1 | NOVEL HOMOPIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF | Leo Pharma A/S (DK) | 2013-05-15 | — | — | EP | disclosed |
| WO-2012003829-A1 | NOVEL HOMOPIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF | LEO PHARMA A/S (DK) | 2012-01-12 | — | — | WO | disclosed |